No abstract available
MeSH terms
-
Angiogenesis Inhibitors*
-
Animals
-
Antibodies, Monoclonal
-
Antibodies, Monoclonal, Humanized
-
Antineoplastic Agents*
-
Benzenesulfonates
-
Bevacizumab
-
Drug Design*
-
Humans
-
Indoles
-
Neoplasms / blood supply
-
Neoplasms / drug therapy*
-
Neoplastic Cells, Circulating
-
Neovascularization, Pathologic / genetics*
-
Neovascularization, Physiologic / genetics
-
Niacinamide / analogs & derivatives
-
Phenylurea Compounds
-
Pyridines
-
Pyrroles
-
Receptors, Vascular Endothelial Growth Factor / antagonists & inhibitors
-
Receptors, Vascular Endothelial Growth Factor / immunology
-
Receptors, Vascular Endothelial Growth Factor / physiology*
-
Recombinant Fusion Proteins
-
Signal Transduction
-
Sorafenib
-
Sunitinib
-
Vascular Endothelial Growth Factor A / antagonists & inhibitors
-
Vascular Endothelial Growth Factor A / immunology
-
Vascular Endothelial Growth Factor A / physiology*
Substances
-
Angiogenesis Inhibitors
-
Antibodies, Monoclonal
-
Antibodies, Monoclonal, Humanized
-
Antineoplastic Agents
-
Benzenesulfonates
-
Indoles
-
Phenylurea Compounds
-
Pyridines
-
Pyrroles
-
Recombinant Fusion Proteins
-
Vascular Endothelial Growth Factor A
-
aflibercept
-
Niacinamide
-
Bevacizumab
-
Sorafenib
-
Receptors, Vascular Endothelial Growth Factor
-
Sunitinib